NCEL logo
NCEL NASDAQ CH

NewcelX Ltd. - Ordinary Shares

Healthcare · Biotechnology Website · IPO Jan 2021
$2.26
▼ $-0.10 (-4.04%)
Vol 23K
3
Quality Score
fail
Mkt Cap
$8.7M
ROE
-101.0%
D/E
0.00
Beta
0.32
52W
$2–$8

Wall Street Consensus

6 analysts · Apr 2025
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2023-12-31 2024-06-30 2024-12-31 2025-06-30 2025-12-03 2026-01-02
ROE (TTM) 3.9% -101.0% -101.0% -101.0%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00
Current Ratio 0.23 0.15 2.69 2.77 2.77 2.77

Key Ratios

ROA (TTM)
-65.9%
EPS (TTM)
$-5.27
52W High
$7.64
52W Low
$2.48
$2.48 52-Week Range $7.64

How does NCEL compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

NCEL AAPG ABEO ABOS ABP

NCEL valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

NCEL profitability vs Biotechnology peers

ROE
-101.0%
50% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-65.9%
41% below peers (-46.7%)
vs Peers
vs Industry
Weak

NCEL financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.8
38% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
67% below peers (1.0)
vs Peers
vs Industry
More volatile

NCEL fundamentals radar

NCEL Peer median Industry

NCEL profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

NCEL vs peers: key metrics